What is Aspect Biosystems?
Aspect Biosystems Ltd. is a privately held biotechnology firm at the forefront of 3D bioprinting and tissue engineering. Its proprietary Lab-on-a-Printer platform technology is instrumental in advancing fundamental biology research, disease modeling, and the development of new therapeutics and regenerative medicine applications. Beyond its internal initiatives, Aspect Biosystems actively pursues strategic partnerships with pharmaceutical, biotechnology companies, and academic institutions to engineer commercially viable tissues that expedite the discovery and development of innovative drugs and treatments.
How much funding has Aspect Biosystems raised?
Aspect Biosystems has raised a total of $215M across 4 funding rounds:
Other Financing Round
$1M
Series A
$20M
Series B
$115M
Unspecified
$79M
Other Financing Round (2018): $1M with participation from Genome British Columbia
Series A (2020): $20M led by Rhino Ventures, Pallasite Ventures, Pangaea Ventures, and Radical Ventures
Series B (2025): $115M supported by Pallasite Ventures, Novo Nordisk, Radical Ventures, Rhino Ventures, JDRF T1D Fund, Dimension Data, InBC Investment, and Pangaea Ventures
Unspecified (2026): $79M featuring Government of Canada
Key Investors in Aspect Biosystems
Pallasite Ventures
Pallasite Ventures is an agile venture capital firm based in Vancouver, Canada, that provides early-stage financing for high-growth companies across various industries, including tech and consumer products. The firm focuses on Seed and Series A investments, offering capital between $100k and $1.5m USD to support companies with strong leadership and market vision.
Pangaea Ventures
Pangaea Ventures is a leading venture capital firm specializing in hard tech, focusing on investments in start-up companies that utilize advancements in materials, chemistry, and biology to tackle significant global challenges. With over 25 years of experience, they aim to drive industrial transformation and promote sustainability through their portfolio, which includes leaders in clean energy and biotechnology.
Radical Ventures
Radical Ventures is a venture capital firm investing in bold entrepreneurs developing and applying artificial intelligence and other deep technologies to invent the future. Based in Toronto, Radical Ventures launched a US $350 Million fund in 2019 focused on Series A investments.
What's next for Aspect Biosystems?
With the infusion of $79M in its latest strategic investment and a cumulative backing of $215M, Aspect Biosystems is poised for significant expansion. The company's focus on strategic partnerships, coupled with its advanced bioprinting technology, positions it to address critical unmet needs in drug development and regenerative medicine. Future growth is anticipated to involve scaling its platform, forging new collaborations, and potentially moving towards clinical applications, solidifying its role as a key player in the biotech landscape.
See full Aspect Biosystems company page
